Needle-Free Influenza Vaccine Market
1 Needle-Free Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Needle-Free Influenza Vaccine
1.2 Needle-Free Influenza Vaccine Segment by Type
1.2.1 Global Needle-Free Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Live Attenuated Influenza Vaccine
1.2.3 Split Influenza Vaccine
1.3 Needle-Free Influenza Vaccine Segment by Application
1.3.1 Global Needle-Free Influenza Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 3-17 Years
1.3.3 Others
1.4 Global Needle-Free Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Needle-Free Influenza Vaccine Revenue 2017-2028
1.4.2 Global Needle-Free Influenza Vaccine Sales 2017-2028
1.4.3 Needle-Free Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Needle-Free Influenza Vaccine Market Competition by Manufacturers
2.1 Global Needle-Free Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Needle-Free Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Needle-Free Influenza Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Needle-Free Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Needle-Free Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Needle-Free Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Needle-Free Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Needle-Free Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Needle-Free Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Needle-Free Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Needle-Free Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Needle-Free Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Needle-Free Influenza Vaccine Sales by Country
3.3.2 North America Needle-Free Influenza Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Needle-Free Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Needle-Free Influenza Vaccine Sales by Country
3.4.2 Europe Needle-Free Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Needle-Free Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Needle-Free Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Needle-Free Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 SEA
3.6 Latin America Needle-Free Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Needle-Free Influenza Vaccine Sales by Country
3.6.2 Latin America Needle-Free Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Needle-Free Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Needle-Free Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Needle-Free Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Needle-Free Influenza Vaccine Historic Market Analysis by Type
4.1 Global Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Needle-Free Influenza Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Needle-Free Influenza Vaccine Price by Type (2017-2022)
5 Global Needle-Free Influenza Vaccine Historic Market Analysis by Application
5.1 Global Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Needle-Free Influenza Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Needle-Free Influenza Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Needle-Free Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AstraZeneca Needle-Free Influenza Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Needle-Free Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Cipla Needle-Free Influenza Vaccine Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 BCHT
6.3.1 BCHT Corporation Information
6.3.2 BCHT Description and Business Overview
6.3.3 BCHT Needle-Free Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 BCHT Needle-Free Influenza Vaccine Product Portfolio
6.3.5 BCHT Recent Developments/Updates
7 Needle-Free Influenza Vaccine Manufacturing Cost Analysis
7.1 Needle-Free Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Needle-Free Influenza Vaccine
7.4 Needle-Free Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Needle-Free Influenza Vaccine Distributors List
8.3 Needle-Free Influenza Vaccine Customers
9 Needle-Free Influenza Vaccine Market Dynamics
9.1 Needle-Free Influenza Vaccine Industry Trends
9.2 Needle-Free Influenza Vaccine Market Drivers
9.3 Needle-Free Influenza Vaccine Market Challenges
9.4 Needle-Free Influenza Vaccine Market Restraints
10 Global Market Forecast
10.1 Needle-Free Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Needle-Free Influenza Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Needle-Free Influenza Vaccine by Type (2023-2028)
10.2 Needle-Free Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Needle-Free Influenza Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Needle-Free Influenza Vaccine by Application (2023-2028)
10.3 Needle-Free Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Needle-Free Influenza Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Needle-Free Influenza Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Needle-Free Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Dose) & (US$ Million)
Table 2. Global Needle-Free Influenza Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Dose) & (US$ Million)
Table 3. Global Needle-Free Influenza Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Needle-Free Influenza Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Needle-Free Influenza Vaccine Sales (K Dose) of Key Manufacturers (2017-2022)
Table 6. Global Needle-Free Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Needle-Free Influenza Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Needle-Free Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Needle-Free Influenza Vaccine Average Price (US$/Dose) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Needle-Free Influenza Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Needle-Free Influenza Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Needle-Free Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Influenza Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Needle-Free Influenza Vaccine Sales by Region (2017-2022) & (K Dose)
Table 16. Global Needle-Free Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Needle-Free Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Needle-Free Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
Table 20. North America Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
Table 24. Europe Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Needle-Free Influenza Vaccine Sales by Region (2017-2022) & (K Dose)
Table 28. Asia Pacific Needle-Free Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Needle-Free Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Needle-Free Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
Table 32. Latin America Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
Table 36. Middle East and Africa Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Needle-Free Influenza Vaccine Sales by Type (2017-2022) & (K Dose)
Table 40. Global Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Needle-Free Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Needle-Free Influenza Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Needle-Free Influenza Vaccine Price by Type (2017-2022) & (US$/Dose)
Table 44. Global Needle-Free Influenza Vaccine Sales (K Dose) by Application (2017-2022)
Table 45. Global Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Needle-Free Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Needle-Free Influenza Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Needle-Free Influenza Vaccine Price by Application (2017-2022) & (US$/Dose)
Table 49. AstraZeneca Corporation Information
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Needle-Free Influenza Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 52. AstraZeneca Needle-Free Influenza Vaccine Product
Table 53. AstraZeneca Recent Developments/Updates
Table 54. Cipla Corporation Information
Table 55. Cipla Description and Business Overview
Table 56. Cipla Needle-Free Influenza Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 57. Cipla Needle-Free Influenza Vaccine Product
Table 58. Cipla Recent Developments/Updates
Table 59. BCHT Corporation Information
Table 60. BCHT Description and Business Overview
Table 61. BCHT Needle-Free Influenza Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 62. BCHT Needle-Free Influenza Vaccine Product
Table 63. BCHT Recent Developments/Updates
Table 64. Production Base and Market Concentration Rate of Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Needle-Free Influenza Vaccine Distributors List
Table 67. Needle-Free Influenza Vaccine Customers List
Table 68. Needle-Free Influenza Vaccine Market Trends
Table 69. Needle-Free Influenza Vaccine Market Drivers
Table 70. Needle-Free Influenza Vaccine Market Challenges
Table 71. Needle-Free Influenza Vaccine Market Restraints
Table 72. Global Needle-Free Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Dose)
Table 73. Global Needle-Free Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 74. Global Needle-Free Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 75. Global Needle-Free Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 76. Global Needle-Free Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Dose)
Table 77. Global Needle-Free Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 78. Global Needle-Free Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 79. Global Needle-Free Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 80. Global Needle-Free Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 81. Global Needle-Free Influenza Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 82. Global Needle-Free Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 83. Global Needle-Free Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Needle-Free Influenza Vaccine
Figure 2. Global Needle-Free Influenza Vaccine Market Share by Type in 2021 & 2028
Figure 3. Live Attenuated Influenza Vaccine Product Picture
Figure 4. Split Influenza Vaccine Product Picture
Figure 5. Global Needle-Free Influenza Vaccine Market Share by Application in 2021 & 2028
Figure 6. 3-17 Years
Figure 7. Others
Figure 8. Global Needle-Free Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Needle-Free Influenza Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Needle-Free Influenza Vaccine Sales (2017-2028) & (K Dose)
Figure 11. Needle-Free Influenza Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Needle-Free Influenza Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Needle-Free Influenza Vaccine Players: Market Share by Revenue in 2021
Figure 14. Needle-Free Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Needle-Free Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Needle-Free Influenza Vaccine Sales Market Share by Region in 2021
Figure 17. Global Needle-Free Influenza Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Needle-Free Influenza Vaccine Revenue Market Share by Region in 2021
Figure 19. United States Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. SEA Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Mexico Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Brazil Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Argentina Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Turkey Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Saudi Arabia Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. UAE Needle-Free Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Sales Market Share of Needle-Free Influenza Vaccine by Type (2017-2022)
Figure 39. Manufacturing Cost Structure of Needle-Free Influenza Vaccine
Figure 40. Manufacturing Process Analysis of Needle-Free Influenza Vaccine
Figure 41. Needle-Free Influenza Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
